1.1 Scope of Research

1.2 Research Methodology

1.2 Research Methodology (continued)

1.3 Key Findings: Abuse-Deterrent Opioids, Non-Narcotics and Monoclonal Antibodies Are Likely to Emerge as the Preferred Analgesics

2.1 Overview of Pain Disorders

2.2 Snapshot of Existing and Emerging Pain Therapies

2.3 Key Application Areas for Pain Treatments: Low Back Pain, Migraine and Arthritic Pain Are Some of the Key Application Areas

2.4 Treatment of Low Back Pain: A Brief Overview

2.5 Stem Cell and Monoclonal Antibody Therapies Are Likely to Emerge as Promising Treatment Options for Low Back Pain

2.6 Clinical Management of Migraine: Summary of Existing and Emerging Therapies

2.7 Emerging Migraine Therapies: Monoclonal Antibodies Are Emerging as a Promising Drug Class

2.8 Arthritic Pain Relief: Overview of Prevalent and Emerging Clinical Management Strategies

2.9 Biotherapies Are Likely to Emerge as the Preferred Treatment Alternative for the Management of Arthritic Pain

2.10 Overview of Existing and Emerging Treatment Options for Fibromyalgia

2.11 Emerging Treatment Options for Fibromyalgia: A Brief Summary

2.12 Clinical Management Strategies for Coping with Cancer Pain

2.13 Recent Developments in Cancer Pain Therapy: Novel Opioid Formulations on the Rise

2.14 Overview of Neuropathic Pain Medications

2.15 Emerging Therapies for Neuropathic Pain: A Brief Summary

2.16 Treatment Strategies for Post-Operative Pain

2.17 Recent Advances across Post-Operative Pain Therapies

2.18 Timeline Overview for US FDA Approved Analgesics

2.19 Non-Narcotics Dominate the Analgesic Pipeline

3.1 Therapeutic Hotspots for Pain Disorders

3.2 Key Market Drivers and Challenges across the Global Analgesics Markets

3.3 Increasing Demand for Non-Narcotic Medications is Likely to Fuel Market Growth for Analgesics

3.4 Global Analgesic Markets Need to Address Pain Assessment and Reimbursement Challenges

4.1 Overview of the Collaborative Landscape

4.2 Big Pharma Partnerships Fuel New Product Developments

4.3 Key Product Development Collaborations for Pain Management

4.4 Key Research and Development Collaborations across the Global Analgesics Market

4.5 Licensing and Marketing Collaborations in the Pain Management Industry

4.6 Global Adoption Scenario

5.1 Technology Roadmap for the Global Pain Management Sector

5.2 Key Conclusions for the Global Analgesics Market

6.1 Patent Search Scope

6.2 Patent Publishing Trends

6.3 Leading Patent Holders

6.4 Leading Patent Offices

6.5 Key Patents Related to Analgesics – Non-Opioid & Opioid Therapies

6.6 Key Patents Related to Analgesics – Antibody Therapies

Legal Disclaimer

7.1 Advances in Musculoskeletal and Back Pain Therapy

7.2 Key Contacts

7.2 Key Contacts (continued)

8.1 The Frost & Sullivan Story

8.2 Value Proposition: Future of Your Company & Career

8.3 Global Perspective

8.4 Industry Convergence

8.5 360º Research Perspective

8.6 Implementation Excellence

8.7 Our Blue Ocean Strategy